378 Page St,,
Stoughton, Massachusetts 02072
BTI has been manufacturing life science research products for more than 30 years, with a commitment to its customers of technology, quality and value. Its product line includes specialty proteins, cell culture additives and highly specific immunoassay tools, which Alfa Aesar will continue to build upon as it expands its portfolio of unique biochemical products for the researcher.
Biomedical Technologies was acquired by Alfa Aesar & Co KG on September 16, 2013.
Join Mergr to view all 187 acquisitions of medical products companies in 2013, including 26 acquisitions by private equity firms, and 161 by strategics.
Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2013. The largest medical products acquisition in 2013 was Bausch & Lomb - which was acquired by Valeant Pharmaceuticals International for $8.7B.
Join Mergr to view this profile - and discover more medical products acquisitions of companies like Biomedical Technologies.
No obligation. Cancel anytime.